UK-396,082

DB12099InvestigationalSmall molecule

UK-396,082 has been used in trials studying the basic science of Safety, Phase 1, Toleration, Multiple Dose, and Pharmacokinetic.

Chemical structure of UK-396,082
Formula / weight
C12H21N3O2 · 239.314 g/mol (avg)
Code names
UK-396082

Resolves to

Compound
UNII2Q5861SUIGCAS400044-47-5ChEMBLCHEMBL398110PubChem11241908
Structure
InChIKeyOTDGPKRCQXSTPV-JTQLQIEISA-NSMILES[H][C@](CCCN)(CC1=CN(CCC)C=N1)C(O)=O
Targets
Q96IY4CPB2

What you can answer from here — as of January 29, 2025

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
1Clinical trialPhase, status and sponsor resolved per trial
Sign in
4+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with UK-396,082, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In